Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cypher in Japan

This article was originally published in The Gray Sheet

Executive Summary

J&J/Cordis will begin distributing the sirolimus-eluting coronary stent mid-year, co-marketed by Guidant, following Japanese marketing approval, the firm announces March 31. The release will coincide with anticipated reimbursement approval. Japan's Ministry of Health, Labor & Welfare recently lowered reimbursement levels for catheters for cardiac surgery with stents (1"The Gray Sheet" March 1, 2004, p. 27). Approximately 166,000 angioplasties are performed annually in Japan, 70% with stent placement, according to the firm...

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts